Jason Gersting is a partner in the Orange County office. He focuses on patent and trademark prosecution and strategic intellectual property portfolio management in the biotechnology and life science industries.
Dr. Gersting’s practice includes patent and trademark prosecution, intellectual property due diligence, counseling on licensing, infringement and validity issues, and strategic management of patent and other intellectual property assets. He currently represents clients in a wide range of technology areas, including stem cell therapy and regenerative medicine, biotechnology, medical devices, aesthetics and personal care products, and nutraceuticals. He also represents foreign associates in procuring U.S. patent protection for their clients in biotechnology and life sciences.
Prior to joining the firm, Dr. Gersting earned his Ph.D. and J.D. from the University of Florida, where his research focused on role of fetal neuroendocrine signaling and prostaglandins in the initiation of labor and delivery at the conclusion of pregnancy. Before law school, Dr. Gersting worked as a research scientist in a laboratory focused on non-traditional roles of hematopoietic growth factors on the developing fetal gastrointestinal tract. He also earned his master’s degree by developing methods to analyze differential expression of calcium channels in response to disease or injury.
Dr. Gersting joined the firm in 2008.
Recognized by The Legal 500 "United States" for Patent Prosecution (2022)
Dr. Gersting was named to Legal Media Group's (LMG) inaugural "Rising Stars" guide (2015).
Development of prostaglandin endoperoxide synthase expression in the ovine fetal central nervous system and pituitary., Gersting JA, Schaub CE, Wood CE, Gene Expr. Patterns 9(8):603-11 (2009).
Inhibition of brain prostaglandin endoperoxide synthase-2 prevents the preparturient increase in fetal adrenocorticotropin secretion in the sheep fetus., Gersting J, Schaub CE, Keller-Wood M, Wood CE., Endocrinology 149(8):4128-36 (2008).
Schaub CE, Gersting JA, Keller-Wood M, Wood CE., Development of ER-alpha and ER-beta expression in the developing ovine brain and pituitary., Gene Expr Patterns 8(6):457-63 (2008).
Keller-Wood M, Powers MJ, Gersting JA, Ali N, Wood CE., Genomic analysis of neuroendocrine development of fetal brain-pituitary-adrenal axis in late gestation., Physiol Genomics24(3):218-24, 2006.
Gersting JA, Christensen RD, Calhoun DA., Effects of enterally administering granulocyte colony-stimulating factor to suckling mice., Pediatr Res. 55(5):802-6, 2004.
Gersting JA, Kotto-Kome CA, Du Y, Christensen RD, Calhoun DA., Bioavailability of granulocyte colony-stimulating factor administered enterally to suckling mice., Pharmacol Res. 48(6):643-7, 2003.
Gersting JA, Du Y, Christensen RD, Calhoun DA., Messenger RNA expression of granulocyte colony-stimulating factor receptor isoforms in the fetus., Biol Neonate 83(3):191-6, 2003.
Gersting JA, Bidasee KR, Dinçer UD, Besch HR Jr., Determination of complement of mRNA encoding inositol 1,4,5-trisphosphate receptor isoforms in rat tissues using relative-polymerase chain reaction., Anal Biochem. 294(2):188-90, 2001.